Potential Clinical Implications of the Urotensin II Receptor Antagonists.
about
A Novel Urotensin II Receptor Antagonist, KR-36996 Inhibits Smooth Muscle Proliferation through ERK/ROS Pathway.Association between human urotensin II and essential hypertension--a 1:1 matched case-control studyThe orally active urotensin receptor antagonist, KR36676, attenuates cellular and cardiac hypertrophyA closer look at the role of urotensin II in the metabolic syndrome.Blockade of Urotensin II Receptor Prevents Vascular Dysfunction.Small molecule and peptide therapies for chronic heart failure: a patent review (2011 - 2014).Urotensin-II promotes vascular smooth muscle cell proliferation through store-operated calcium entry and EGFR transactivation.New insight into the binding mode of peptides at urotensin-II receptor by Trp-constrained analogues of P5U and urantide.Urotensin II promotes aldosterone expression in rat aortic adventitial fibroblasts.Urotensin-II peptidomimetic incorporating a non-reducible 1,5-triazole disulfide bond reveals a pseudo-irreversible covalent binding mechanism to the urotensin G-protein coupled receptor.Urantide conformation and interaction with the urotensin-II receptor.
P2860
Q33655911-A4210964-3E44-4A70-99F1-B10F88F8DEDCQ35067629-1ABD6AC4-BD6C-49FA-A765-13BAEC1B2A8CQ35538538-EB532765-A194-44CF-930D-EC7E25389F73Q36492706-CAE05905-9828-456C-AACA-B8D6D8539F49Q37235264-6D5E9EB8-5738-4120-B42D-C29B20FA2510Q38546917-BC2C863B-6B96-4E76-9B1B-D3FD6C71742AQ41872921-55F8BA3C-9061-4185-9494-32ECAEE21FD8Q44114224-64F85EEF-B102-4553-BAF8-58BA98EC1576Q47275813-096A9B9C-CB41-4365-B7E3-18866E555D76Q50992476-9746B19A-F37C-478D-8AB1-99B2F59CEE4DQ54414485-E58D547E-9CB2-4189-AEE1-787148626546
P2860
Potential Clinical Implications of the Urotensin II Receptor Antagonists.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Potential Clinical Implications of the Urotensin II Receptor Antagonists.
@ast
Potential Clinical Implications of the Urotensin II Receptor Antagonists.
@en
type
label
Potential Clinical Implications of the Urotensin II Receptor Antagonists.
@ast
Potential Clinical Implications of the Urotensin II Receptor Antagonists.
@en
prefLabel
Potential Clinical Implications of the Urotensin II Receptor Antagonists.
@ast
Potential Clinical Implications of the Urotensin II Receptor Antagonists.
@en
P2093
P2860
P356
P1476
Potential Clinical Implications of the Urotensin II Receptor Antagonists.
@en
P2093
Adel Giaid
Emilie Kane
Philip Tsoukas
P2860
P356
10.3389/FPHAR.2011.00038
P577
2011-07-22T00:00:00Z